Physician

Alexander Evan Ehrlich, M.D.

According to 2025 Medicare claims, Alexander Ehrlich, M.D. (NPI: 1215932876) practices dermatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. Ehrlich uses personal NPI as billing NPI and primary practice location at 19103-5767.

Ehrlich's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 787 traditional Medicare patients, billed 4,368 HCPCS/CPT codes, and received $225,137 in Medicare payments. The top billing code was 17281 (Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm). Part D data shows 905 prescription claims across 362 beneficiaries totaling $20,345 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have fallen sharply in recent years, from $97,724 to $20,345. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$144K$288K2015 Medicare payment: $288,011 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $265,867 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $264,416 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $252,701 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $255,208 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $192,174 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $269,457 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $288,065 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $278,535 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $225,137 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0775,147$288,011
20161,0415,162$265,867
20171,0155,316$264,416
20181,0544,905$252,701
20191,0454,746$255,208
20208113,628$192,174
20218574,357$269,457
20228874,882$288,065
20239024,691$278,535
20247874,368$225,137

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$49K$98K2015 Drug cost: $97,724 (USD; Tot_Drug_Cst)2016 Drug cost: $59,857 (USD; Tot_Drug_Cst)2017 Drug cost: $66,994 (USD; Tot_Drug_Cst)2018 Drug cost: $62,377 (USD; Tot_Drug_Cst)2019 Drug cost: $64,772 (USD; Tot_Drug_Cst)2020 Drug cost: $48,695 (USD; Tot_Drug_Cst)2021 Drug cost: $36,662 (USD; Tot_Drug_Cst)2022 Drug cost: $35,043 (USD; Tot_Drug_Cst)2023 Drug cost: $25,668 (USD; Tot_Drug_Cst)2024 Drug cost: $20,345 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015401897$97,724
2016363809$59,857
2017366835$66,994
2018409914$62,377
2019426966$64,772
2020397948$48,695
2021381934$36,662
2022380879$35,043
2023368837$25,668
2024362905$20,345

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17281Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm155230$104
17110Destruction of skin growth, 1-14 growths122148$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more629951$62
17000Destruction of precancer skin growth, 1 growth398595$30
17003Destruction of precancer skin growth, 2-14 growths2791,100$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate711,521$2,546
KetoconazoleKetoconazole1543,938$2,195
MetronidazoleMetronidazole13315$1,181
FluorouracilFluorouracil20558$1,118
Doxycycline HyclateDoxycycline Hyclate30816$908

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Alexander Evan Ehrlich, M.D.?

Tedicare shows public-source Medicare data for Alexander Evan Ehrlich, M.D. (NPI 1215932876), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexander Evan Ehrlich, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexander Evan Ehrlich, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Alexander Evan Ehrlich, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.